Vascular smooth muscle cell peroxisome proliferator-activated receptor γ protects against endothelin-1-induced oxidative stress and inflammation-Reference-Cited by-同舟云学术

Vascular smooth muscle cell peroxisome proliferator-activated receptor γ protects against endothelin-1-induced oxidative stress and inflammation

Published:2017-07 Issue:7 Volume:35 Page:1390-1401
ISSN:0263-6352
Container-title:Journal of Hypertension
language:en
Short-container-title:

Author:

Idris-Khodja Noureddine,Ouerd Sofiane,Trindade Michelle,Gornitsky Jordan,Rehman Asia,Barhoumi Tlili,Offermanns Stefan,Gonzalez Frank J.,Neves Mario F.,Paradis Pierre,Schiffrin Ernesto L.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine,Physiology,Internal Medicine

Reference44 articles.

1. Vascular endothelin in hypertension;Schiffrin;Vascul Pharmacol,2005

2. Endothelium-restricted overexpression of human endothelin-1 causes vascular remodeling and endothelial dysfunction;Amiri;Circulation,2004

3. Inducible human endothelin-1 overexpression in endothelium raises blood pressure via endothelin type A receptors;Rautureau;Hypertension,2015

4. Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension;Barroso;Nature,1999

5. Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial;Dormandy;Lancet,2005

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Canagliflozin alleviates pulmonary hypertension by activating PPARγ and inhibiting its S225 phosphorylation;Acta Pharmacologica Sinica;2024-05-08

2. Regulation of soluble epoxide hydrolase in renal-associated diseases: insights from potential mechanisms to clinical researches;Frontiers in Endocrinology;2024-02-15

3. The potential effect of natural antioxidants on endothelial dysfunction associated with arterial hypertension;Frontiers in Cardiovascular Medicine;2024-02-02

4. Canagliflozin alleviates pulmonary hypertension partially by inhibition of PPARγ S225 phosphorylation and PPARγ-mediated suppression of oxidative stress;2023-04-20

5. Bioinformatics Analysis of Key Differentially Expressed Genes in Pericoronary Adipose Tissue Associated with the Diagnosis of Coronary Artery Disease;2022-12-07